KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner von Laurent, Pierre-Antoine, Milic, Marina, Quevrin, Clément, Meziani, Lydia, Liu, Winchygn, Morel, Daphné, Signolle, Nicolas, Clémenson, Céline, Levy, Antonin, Mondini, Michele, Deutsch, Eric

Volltext

Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer von Levy, Antonin, Khalifa, Jonathan, Martin, Etienne, Botticella, Angela, Quevrin, Clément, Lavaud, Pernelle, Aldea, Mihaela, Besse, Benjamin, Planchard, David, Barlesi, Fabrice, Deutsch, Eric, Massabeau, Carole, Doyen, Jérôme, Le Péchoux, Cécile

Volltext

An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer von Levy, Antonin, Morel, Daphné, Texier, Matthieu, Sun, Roger, Durand-Labrunie, Jerome, Rodriguez-Ruiz, Maria E, Racadot, Severine, Supiot, Stéphane, Magné, Nicolas, Cyrille, Stacy, Louvel, Guillaume, Massard, Christophe, Verlingue, Loic, Bouquet, Fanny, Bustillos, Alberto, Bouarroudj, Lisa, Quevrin, Clément, Clémenson, Céline, Mondini, Michele, Meziani, Lydia, Tselikas, Lambros, Bahleda, Rastilav, Hollebecque, Antoine, Deutsch, Eric

Volltext

Local control strategies for management of NSCLC with oligoprogressive disease von Mavrikios, Antoine, Remon, Jordi, Quevrin, Clément, Mercier, Olaf, Tselikas, Lambros, Botticella, Angela, Nicolas, Eliot, Deutsch, Eric, Besse, Benjamin, Planchard, David, Barlesi, Fabrice, Le Péchoux, Cécile, Levy, Antonin

Volltext

Is Local Ablative Stereotactic Radiation Therapy a Valuable Rescue Strategy for Time on Drug in Patients Enrolled in Phase I Trials? von Mavrikios, Antoine, Baldini, Capucine, Loriot, Yohann, Hénon, Clémence, Marabelle, Aurélien, Postel-Vinay, Sophie, Champiat, Stéphane, Danlos, François-Xavier, Quevrin, Clément, Lopes, Eloise, Gazzah, Anas, Bahleda, Rastislav, Massard, Christophe, Deutsch, Eric, Levy, Antonin

Volltext